1/ History is being made today! Canary Capital just filed the first US Staked $INJ ETF with the SEC, giving institutions and everyday investors a regulated path to access the native Injective token through traditional brokerages and banking rails. Here's why it's a big deal 🧵

2/ Canary Capital has established itself as a pioneer in the crypto ETF space, having submitted applications for only a select few digital asset ETFs, including $XRP and $SOL. Now @CanaryFunds is bringing that same institutional expertise to Injective.

3/ This filing comes as the CLARITY Act enters a Congressional vote, creating unprecedented regulatory certainty for digital assets. The legislation establishes clear boundaries between the SEC and CFTC, providing the framework needed for innovative products like staked ETFs.

4/ Unlike traditional crypto ETFs that simply hold tokens, this staked $INJ ETF would actively participate in Injective’s proof-of-stake consensus mechanism, enabling users to earn yield while contributing to network security. This is how institutional DeFi should work.

5/ The European launch of 21Shares’s AINJ ETP showed strong demand for regulated Injective products. The US market, with its larger capital pools and advanced institutional infrastructure, offers an even bigger opportunity for Injective adoption.

6/ The ETF filing also coincides with Injective’s expanding engagement with the SEC to shape clear rules for onchain finance, demonstrating our commitment to responsible growth and our vision to make the US the global hub for crypto.